SRX 0.00% 17.5¢ sierra rutile holdings limited

Ann: Soramic Clinical Study Results to be Presented at EASL/ILC, page-18

  1. 16,707 Posts.
    lightbulb Created with Sketch. 2386
    "The PP groups show a non significant difference, which is easily explainable by the massive differential in drop out rates between the two groups (80% vs 50%)"

    There most certainly is more to say. What it tells you is that the reasons for the difference in outcome need to be explained, since it suggests that possibly many patients missed out on having optimum treatment. That treatment might well have extended their lives. Its very important not to simply dismiss it, it may well be the result of poor management or conduct of the study.
    Last edited by whytee: 18/04/18
 
watchlist Created with Sketch. Add SRX (ASX) to my watchlist
(20min delay)
Last
17.5¢
Change
0.000(0.00%)
Mkt cap ! $74.27M
Open High Low Value Volume
17.5¢ 17.5¢ 17.5¢ $2.587K 14.78K

Buyers (Bids)

No. Vol. Price($)
13 6407725 17.5¢
 

Sellers (Offers)

Price($) Vol. No.
18.0¢ 1792238 19
View Market Depth
Last trade - 13.11pm 31/07/2024 (20 minute delay) ?
SRX (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.